Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
21/05/2025
Listed stock Ningde era's turnover reaches 10 billion yuan, up 6.08% now.
Latest
2 m ago
The Ministry of Trade of Malaysia expressed that the Malaysian government did not develop, coordinate, or endorse the artificial intelligence project involving a Malaysian company and Huawei Technologies Co., Ltd. as reported by the local media.
3 m ago
Silicon Industry Branch: Reduction of supply-side production eases industry pressure, polycrystalline silicon prices expected to stabilize and stop falling.
4 m ago
Reporters learned from JD.com that after the comprehensive open source in February this year, JD Health's self-developed medical big model "Jingyi Qianxun" will welcome a major upgrade to version 2. The newly upgraded "Jingyi Qianxun" medical big model integrates clinical multi-source information through multi-modal perception and deep retrieval technology to build a decision support system that is closer to real scenarios. It is understood that in the field of specialized disease treatment, "Jingyi Qianxun" version 2 has shown breakthrough value. It provides personalized diagnosis and treatment for clinical doctors by combining evidence-based medicine with individual patient data in complex scenarios such as malignant tumors and cardiovascular diseases. The imaging pathology diagnosis module can quickly analyze images and pathology images, greatly reducing the burden on doctors to read films and assisting in treatment decisions. (Guoshi Direct Line)
4 m ago
JD Health's "Jingyi Qianxun" medical model will undergo a second upgrade.
4 m ago
Lyon: First gives a "highly confident outperform market" rating to Ningde Times (03750.HK) with a target price of 385 Hong Kong dollars.
See all latest
